Research output per year
Research output per year
Research activity per year
My research focuses on using circulating tumor DNA (ctDNA) as a minimally invasive biomarker to detect molecular residual disease, monitor disease recurrence, and guide treatment decisions in colorectal cancer. A key part of my work is serial ctDNA analysis, which allows me to estimate tumor growth rates, which could be a promising tool for identifying particularly aggressive disease and guiding timely intervention.
I’m a translational cancer researcher with a background in Molecular Medicine (MSc and PhD, Aarhus University). I specialize in circulating tumor DNA (ctDNA) analysis for improving cancer treatment, with a special focus on colorectal cancer.
I work on the development and clinical application of circulating tumor DNA (ctDNA) as a biomarker in colorectal cancer. My focus is on disease monitoring, treatment response evaluation, and early relapse detection through serial ctDNA analysis. I’m involved in both clinical research and method development.
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Henriksen, T. V. (Recipient), 2023
Prize: Prizes, scholarships, distinctions
Henriksen, T. V. (Recipient), 2023
Prize: Prizes, scholarships, distinctions
08/10/2021
1 Media contribution
Press/Media: Press / Media
Henriksen, T. V. & Andersen, C. L.
08/10/2021
1 Media contribution
Press/Media: Press / Media
25/08/2021
1 Media contribution
Press/Media: Press / Media